Targeted Anti-Cancer Treatment: ProTarget Trial

We are studying how effective and safe targeted cancer drugs are for patients with advanced cancer and specific genetic markers. This research may help improve treatment options based on individual genetic profiles.

3-6 months 6-10 visits Efficacy phase (II)No Placebo Investigational Medicines Oral InjectionOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Alecensa

Alecensa is a cancer medicine used to treat certain types of lung cancer caused by specific genetic changes.

Bavencio

Bavencio is a cancer medicine that helps the immune system detect and attack certain tumors.

Cotellic

Cotellic is a cancer medicine used with other drugs to treat advanced melanoma (skin cancer) that has a specific gene mutation.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Alectinib Hydrochloride

Alectinib hydrochloride is a substance that targets lung cancers with an ALK gene change to slow tumor growth and spread.

Atezolizumab

Atezolizumab is a substance that helps the immune system recognize and attack certain cancers by blocking a protein called PD-L1.

Avelumab

Avelumab is a substance that boosts the immune system to help the body recognize and attack certain types of cancer.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Perjeta

Kadcyla

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Aksitinib Alpha-Medical

Aksitinib Sandoz

Aksitinib Teva

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Aalborg University Hospital

Onkologisk

Aalborg, Denmark

Aarhus Universitetshospital

Onkologisk

Århus, Denmark

Rigshospitalet

Onkologisk

Copenhagen, Denmark

Sponsor: Rigshospitalet

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.